APA (7th ed.) Citation

Jan Dolhain, Winnie Janssens, Narcisa Mesaros, Linda Hanssens, & Frederik Fierens. (2018). Hexavalent vaccines: Increasing options for policy-makers and providers. A review of the data supporting interchangeability (substitution with vaccines containing fewer antigens) and mixed schedules from the same manufacturer. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Jan Dolhain, Winnie Janssens, Narcisa Mesaros, Linda Hanssens, and Frederik Fierens. Hexavalent Vaccines: Increasing Options for Policy-makers and Providers. A Review of the Data Supporting Interchangeability (substitution with Vaccines Containing Fewer Antigens) and Mixed Schedules from the Same Manufacturer. Taylor & Francis Group, 2018.

MLA (9th ed.) Citation

Jan Dolhain, et al. Hexavalent Vaccines: Increasing Options for Policy-makers and Providers. A Review of the Data Supporting Interchangeability (substitution with Vaccines Containing Fewer Antigens) and Mixed Schedules from the Same Manufacturer. Taylor & Francis Group, 2018.